ChemChina shifts focus from size to price

tight pricing
By Addison Gong
13 Jun 2019

China National Chemical Corp (ChemChina) surprised the market with a change in strategy for its latest bond offering this week. High profile as always, the state-owned company’s four-tranche transaction was smaller in size, but tighter in price. Addison Gong reports.

Every time ChemChina comes to the capital markets, it leaves a mark.

Just a little over a year ago, the central-government owned Chinese chemicals producer stunned the market with a $6.4bn six-tranche, dual-currency Reg S only transaction, as it sought to refinance debt taken for the acquisition of Syngenta, ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.